KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria
| dc.contributor.author | Hortle, Elinor | |
| dc.contributor.author | Starrs, Lora | |
| dc.contributor.author | Brown, Fiona G. | |
| dc.contributor.author | Jane, Sephen M | |
| dc.contributor.author | Curtis, David J | |
| dc.contributor.author | McMorran, Brendan | |
| dc.contributor.author | Foote, Simon | |
| dc.contributor.author | Burgio, Gaetan | |
| dc.date.accessioned | 2022-11-29T02:55:27Z | |
| dc.date.available | 2022-11-29T02:55:27Z | |
| dc.date.issued | 2019 | |
| dc.date.updated | 2021-11-28T07:29:43Z | |
| dc.description.abstract | Plasmodium falciparum malaria causes half a million deaths per year, with up to 9% of this mortality caused by cerebral malaria (CM). One of the major processes contributing to the development of CM is an excess of host inflammatory cytokines. Recently K+ signaling has emerged as an important mediator of the inflammatory response to infection; we therefore investigated whether mice carrying an ENU induced activation of the electroneutral K+ channel KCC1 had an altered response to Plasmodium berghei. Here we show that KCC1(M935K/M935K )mice are protected from the development of experimental cerebral malaria, and that this protection is associated with an increased CD4+ and TNFa response. This is the first description of a K+ channel affecting the development of experimental cerebral malaria. | en_AU |
| dc.description.sponsorship | We would like to acknowledge Shelley Lampkin and Australian Phenomics Facility (APF) for the maintenance of the mouse colonies. Tis study was funded by the National Health and Medical Research Council of Australia (Program Grant 490037, and Project Grants 605524 and APP1047090), the National Collaborative Research Infrastructure Strategy (NCRIS), the Education Investment Fund from the Department of Education and Training, the Australian Phenomics Network, Howard Hughes Medical Institute and the Bill and Melinda Gates Foundation. | en_AU |
| dc.format.mimetype | application/pdf | en_AU |
| dc.identifier.issn | 2045-2322 | en_AU |
| dc.identifier.uri | http://hdl.handle.net/1885/281320 | |
| dc.language.iso | en_AU | en_AU |
| dc.provenance | This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. Te images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ | en_AU |
| dc.publisher | Nature Publishing Group | en_AU |
| dc.relation | http://purl.org/au-research/grants/nhmrc/490037 | en_AU |
| dc.relation | http://purl.org/au-research/grants/nhmrc/605524 | en_AU |
| dc.relation | http://purl.org/au-research/grants/nhmrc/1047090 | en_AU |
| dc.rights | © The Author(s) 2019 | en_AU |
| dc.rights.license | Creative Commons Attribution 4.0 International License | en_AU |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_AU |
| dc.source | Scientific Reports | en_AU |
| dc.title | KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria | en_AU |
| dc.type | Journal article | en_AU |
| dcterms.accessRights | Open Access | en_AU |
| local.bibliographicCitation.issue | 6356 | en_AU |
| local.bibliographicCitation.lastpage | 11 | en_AU |
| local.bibliographicCitation.startpage | 1 | en_AU |
| local.contributor.affiliation | Hortle, Elinor, College of Health and Medicine, ANU | en_AU |
| local.contributor.affiliation | Starrs, Lora, College of Health and Medicine, ANU | en_AU |
| local.contributor.affiliation | Brown, Fiona G., Monash University | en_AU |
| local.contributor.affiliation | Jane, Sephen M, Royal Melbourne Hospital | en_AU |
| local.contributor.affiliation | Curtis, David J, Monash University | en_AU |
| local.contributor.affiliation | McMorran, Brendan, College of Health and Medicine, ANU | en_AU |
| local.contributor.affiliation | Foote, Simon, College of Health and Medicine, ANU | en_AU |
| local.contributor.affiliation | Burgio, Gaetan, College of Health and Medicine, ANU | en_AU |
| local.contributor.authoruid | Hortle, Elinor, u1002702 | en_AU |
| local.contributor.authoruid | Starrs, Lora, u4301798 | en_AU |
| local.contributor.authoruid | McMorran, Brendan, u5267721 | en_AU |
| local.contributor.authoruid | Foote, Simon, u5697711 | en_AU |
| local.contributor.authoruid | Burgio, Gaetan, u5727247 | en_AU |
| local.description.notes | Imported from ARIES | en_AU |
| local.identifier.absfor | 320102 - Haematology | en_AU |
| local.identifier.absfor | 320211 - Infectious diseases | en_AU |
| local.identifier.absfor | 320407 - Innate immunity | en_AU |
| local.identifier.absseo | 280103 - Expanding knowledge in the biomedical and clinical sciences | en_AU |
| local.identifier.absseo | 200105 - Treatment of human diseases and conditions | en_AU |
| local.identifier.ariespublication | u3102795xPUB2020 | en_AU |
| local.identifier.citationvolume | 9 | en_AU |
| local.identifier.doi | 10.1038/s41598-019-42782-x | en_AU |
| local.identifier.scopusID | 2-s2.0-85064891997 | |
| local.identifier.thomsonID | 4.6521E+11 | |
| local.publisher.url | https://www.nature.com/ | en_AU |
| local.type.status | Published Version | en_AU |
Downloads
Original bundle
1 - 1 of 1
Loading...
- Name:
- s41598-019-42782-x.pdf
- Size:
- 2.07 MB
- Format:
- Adobe Portable Document Format
- Description: